97 related articles for article (PubMed ID: 21140207)
1. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
[TBL] [Abstract][Full Text] [Related]
2. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
Zhu Y; Stevens RG; Leaderer D; Hoffman A; Holford T; Zhang Y; Brown HN; Zheng T
Breast Cancer Res Treat; 2008 Feb; 107(3):421-5. PubMed ID: 17453337
[TBL] [Abstract][Full Text] [Related]
3. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA study.
Rabstein S; Harth V; Justenhoven C; Pesch B; Plöttner S; Heinze E; Lotz A; Baisch C; Schiffermann M; Brauch H; Hamann U; Ko Y; Brüning T;
Chronobiol Int; 2014 Dec; 31(10):1115-22. PubMed ID: 25229211
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
Yang R; Schlehe B; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Volkmann J; Varon R; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
Breast Cancer Res Treat; 2010 Jun; 121(3):693-702. PubMed ID: 19921425
[TBL] [Abstract][Full Text] [Related]
6. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
Zhou X; Chen X; Hu L; Han S; Qiang F; Wu Y; Pan L; Shen H; Li Y; Hu Z
Gynecol Oncol; 2010 May; 117(2):287-90. PubMed ID: 20163849
[TBL] [Abstract][Full Text] [Related]
8. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
[TBL] [Abstract][Full Text] [Related]
10. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression.
Partonen T; Treutlein J; Alpman A; Frank J; Johansson C; Depner M; Aron L; Rietschel M; Wellek S; Soronen P; Paunio T; Koch A; Chen P; Lathrop M; Adolfsson R; Persson ML; Kasper S; Schalling M; Peltonen L; Schumann G
Ann Med; 2007; 39(3):229-38. PubMed ID: 17457720
[TBL] [Abstract][Full Text] [Related]
11. A genetic variant located in miR-423 is associated with reduced breast cancer risk.
Smith RA; Jedlinski DJ; Gabrovska PN; Weinstein SR; Haupt L; Griffiths LR
Cancer Genomics Proteomics; 2012; 9(3):115-8. PubMed ID: 22593246
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic and DNA-binding characterization of the isolated heme-bound basic helix-loop-helix-PAS-A domain of neuronal PAS protein 2 (NPAS2), a transcription activator protein associated with circadian rhythms.
Mukaiyama Y; Uchida T; Sato E; Sasaki A; Sato Y; Igarashi J; Kurokawa H; Sagami I; Kitagawa T; Shimizu T
FEBS J; 2006 Jun; 273(11):2528-39. PubMed ID: 16704425
[TBL] [Abstract][Full Text] [Related]
13. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
Yi C; Mu L; de la Longrais IA; Sochirca O; Arisio R; Yu H; Hoffman AE; Zhu Y; Katsaro D
Breast Cancer Res Treat; 2010 Apr; 120(3):663-9. PubMed ID: 19649706
[TBL] [Abstract][Full Text] [Related]
14. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
Zhu Y; Leaderer D; Guss C; Brown HN; Zhang Y; Boyle P; Stevens RG; Hoffman A; Qin Q; Han X; Zheng T
Int J Cancer; 2007 Jan; 120(2):432-5. PubMed ID: 17096334
[TBL] [Abstract][Full Text] [Related]
15. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
16. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
17. REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility.
Zhang S; Chen H; Zhao X; Cao J; Tong J; Lu J; Wu W; Shen H; Wei Q; Lu D
Oncogene; 2013 Jan; 32(2):242-50. PubMed ID: 22349819
[TBL] [Abstract][Full Text] [Related]
18. Circadian genes and breast cancer susceptibility in rotating shift workers.
Monsees GM; Kraft P; Hankinson SE; Hunter DJ; Schernhammer ES
Int J Cancer; 2012 Dec; 131(11):2547-52. PubMed ID: 22473669
[TBL] [Abstract][Full Text] [Related]
19. Further studies based on better design are needed to explore the association of NPAS2 gene polymorphisms with breast cancer.
Wang F; Zou YF
Breast Cancer Res Treat; 2011 Jun; 127(2):565-8. PubMed ID: 21234674
[No Abstract] [Full Text] [Related]
20. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
Tchatchou S; Jung A; Hemminki K; Sutter C; Wappenschmidt B; Bugert P; Weber BH; Niederacher D; Arnold N; Varon-Mateeva R; Ditsch N; Meindl A; Schmutzler RK; Bartram CR; Burwinkel B
Carcinogenesis; 2009 Jan; 30(1):59-64. PubMed ID: 19028706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
